Holen Sie sich die Stockscreener-App
20.30
6.19%
-1.34
Mineralys Therapeutics Inc Aktie (MLYS) Neueste Nachrichten
An officer's proposed share sale at Mineralys Therapeutics (MLYS) lists a $78.1K market value. - Stock Titan
Mineralys Therapeutics CEO Jon Congleton sells $1.9m MLYS stock By Investing.com - Investing.com South Africa
Mineralys Therapeutics Presents New Data for Lorundrostat at the American Heart Association Hypertension Scientific Sessions 2026 - GlobeNewswire Inc.
After a CEO share sale, 528,621 shares remain with Mineralys Therapeutics (MLYS) chief. - Stock Titan
Mineralys Therapeutics Announces Presentation of New Lorundrostat Data at the American Society of Nephrology (ASN) Kidney Week 2026 - GlobeNewswire Inc.
A 75,000-share sale is proposed by a Mineralys (MLYS) officer and director. - Stock Titan
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Form 4 Mineralys Therapeutics Inc For: 24 September By Investing.com - Investing.com Canada
Mineralys Therapeutics director sells $3 million in shares By Investing.com - Investing.com Nigeria
Form 4 Mineralys Therapeutics Inc For: 24 September By Investing.com - Investing.com South Africa
Mineralys Therapeutics director sells $3 million in shares By Investing.com - Investing.com South Africa
Mineralys Therapeutics director sells $3 million in shares - Investing.com
Form 4 Mineralys Therapeutics Inc For: 24 September By Investing.com - Investing.com Nigeria
A fund sold Mineralys (MLYS) shares and still holds more than 7.8 million. - Stock Titan
Form 4 Mineralys Therapeutics Inc For: 22 September By Investing.com - Investing.com Canada
Form 4 Mineralys Therapeutics Inc For: 22 September - Investing.com India
Mineralys Therapeutics CCO Eric Warren sells $209k in stock - Investing.com India
Mineralys Therapeutics CCO Eric Warren sells $209k in stock By Investing.com - Investing.com Nigeria
Form 4 Mineralys Therapeutics Inc For: 22 September By Investing.com - Investing.com Nigeria
Mineralys Therapeutics CCO Eric Warren sells $209k in stock - Investing.com
Fund may sell Mineralys (NASDAQ: MLYS) shares; filing shows the size - Stock Titan
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Mineralys Therapeutics (MLYS) officer lines up new stock option sale - stocktitan.net
A new employee gets Mineralys stock awards covering 14,880 and 11,160 shares - Stock Titan
Mineralys Therapeutics (MLYS) CCO sells 7,438 shares in pre-set plan - Stock Titan
Mineralys Therapeutics director Karydas sells $85,740 in stock By Investing.com - Investing.com Nigeria
Mineralys Therapeutics director Karydas sells $85,740 in stock By Investing.com - Investing.com Australia
Mineralys Therapeutics director Karydas sells $85,740 in stock - Investing.com
Mineralys Therapeutics (MLYS) director sells shares under preset plan - stocktitan.net
Mineralys Therapeutics (NASDAQ: MLYS) executive plans new stock option sale after recent $388K trade - stocktitan.net
Mineralys (NASDAQ: MLYS) officer to sell 3,000 shares via options - stocktitan.net
Mineralys (MLYS) officer to sell 7,709 shares - stocktitan.net
Understanding the Setup: (MLYS) and Scalable Risk - Stock Traders Daily
Mineralys Therapeutics grants inducement equity awards covering 52,080 shares to new hires - Bitget
Mineralys at Wells Fargo conference: lorundrostat launch takes shape By Investing.com - Investing.com Canada
MLYS: Lorundrostat nears approval with strong data, broad market prep, and a focus on parity access - TradingView
Mineralys Therapeutics (NASDAQ: MLYS) insider to sell 2,171 shares via cashless option exercise - Stock Titan
Two new hires get four-year stock awards from Mineralys - stocktitan.net
Mineralys Therapeutics Market Sentiment - Benzinga España
BEAM Stock Price and Chart — NASDAQ:BEAM - TradingView
Mineralys Therapeutics upgraded to Buy ahead of lorundrostat FDA approval and strong market launch. - Pluang
Mineralys: Why I'm Making Stock A Buy Ahead Of Hypertension Approval Decision (MLYS) - Seeking Alpha
Understanding the Setup: (MLYS) and Scalable Risk - Stock Traders Daily
Wells Fargo healthcare conference puts Mineralys management on Sept. 9 agenda - Stock Titan
Mineralys Therapeutics CCO Eric Warren sells $193,188 in shares By Investing.com - Investing.com Nigeria
Mineralys Therapeutics CCO Eric Warren sells $193,188 in shares By Investing.com - Investing.com India
Mineralys Therapeutics CCO Eric Warren sells $193,188 in shares By Investing.com - Investing.com UK
Mineralys (NASDAQ: MLYS) CCO sells 7,437 shares under 10b5-1 plan - stocktitan.net
Mineralys Therapeutics CCO Eric Warren sells $193,188 in shares - Investing.com
Mineralys (NASDAQ: MLYS) insider plans sale after $2,696,321.98 June stock deal - stocktitan.net
3.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):